← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
69 ta ish
Ish: The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková +7
Sharh maqolaOchiq kirish20204 iqtibosABIImmunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko, Abhishek D. Garg, Agnieszka Kaczmarek +3
Sharh maqolaOchiq kirish20124 iqtibosABISafety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer +27
MaqolaOchiq kirish20123 iqtibosABIPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener +4
Sharh maqolaOchiq kirish20163 iqtibosABIUsing immunotherapy to boost the abscopal effect
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld +3
Sharh maqolaOchiq kirish20183 iqtibosABIMitochondrial dysfunction and oxidative stress in heart disease
Jessica N. Peoples, Anita Saraf, Nasab Ghazal +2
Sharh maqolaOchiq kirish20193 iqtibosABIL-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors
Kwangsoo Kim, Jae‐Ho Jeong, Daejin Lim +9
MaqolaOchiq kirish20152 iqtibosABICombined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Elizabeth Allen, Arnaud Jabouille, Lee B. Rivera +8
MaqolaOchiq kirish20172 iqtibosABIReactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
Andromachi Kotsafti, Marco Scarpa, Ignazio Castagliuolo +1
Sharh maqolaOchiq kirish20202 iqtibosABIAnti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
Jihane Boustani, Benoît Lecoester, Jérémy Baude +4
Sharh maqolaOchiq kirish20212 iqtibosABI